Serial Number
97425709
Owner
Monogram Health, Inc.Attorney
Elisabeth A. EvertFiling Date
May 24, 2022
MH MONOGRAM HEALTH KIDNEY ECONOMICS & ANALYTICS Trademark
Serial Number: 97425709
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Elisabeth A. Evert Hitchcock Evert LLP
P.O. Box 131709
Dallas, TX 75313-1709
United States
Trademark Details
Filing Date
May 24, 2022
Registration Date
Not Registered
Published for Opposition
May 23, 2023
Goods & Services
Providing technology services, namely, scientific research, analysis, testing, and design in the field of artificial intelligence predictive analytics for the purpose of identifying patients for enrollment into care management programs, all of the foregoing in connection with the diagnosis and treatment of renal disease and/or the provision of renal benefit management services, including the treatment and management of conditions that are co-morbid with renal disease, namely, cardiovascular disease, hypertension, lung disease, or neurological disease; none of the foregoing including the provision of medical or diagnostic testing services, or the development of diagnostic tests, to determine the drug sensitivity and drug resistance of others for diagnostic or treatment purposes
Business management services, including population health management services, for healthcare providers, programs, networks, and insurers in the field of chronic health condition care management and medical coordination; business management services, including population health management services, namely, administration of business program that supports efforts of healthcare providers, programs, networks, and insurers to improve patient health outcomes and cost of care; providing business, administrative and coordination/management services to healthcare providers, programs, networks, and insurers, namely, medical cost management, and medical practice management for others, all to improve patient health outcomes and cost of care, all of the foregoing in connection with the diagnosis and treatment of renal disease and/or the provision of renal benefit management services, including the treatment and management of conditions that are co-morbid with renal disease, namely, cardiovascular disease, hypertension, lung disease, or neurological disease; none of the foregoing including the provision of medical or diagnostic testing services, or the development of diagnostic tests, to determine the drug sensitivity and drug resistance of others for diagnostic or treatment purposes
